New research suggests enhancing the brain’s own immune cells could help clear plaques associated with Alzheimer’s disease.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

The amyloid-β precursor protein (APP) helps to form links between the brain’s neurons. It has been highly studied because its ...

For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

The brain of a US woman with Down syndrome showed the classic signs of Alzheimer’s disease upon her death, yet she remained ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Chicago area scientists have identified the genes that drive the process of Alzheimer’s disease and are working to make the drug Lecanemab even better by identifying which genes are active ...

If amyloid plaques can be cleared from the brain before they trigger the formation of tau pathology — the key driver of cognitive decline in Alzheimer's patients — the cascade is halted before ...